Advertisement

Topics

Gene Therapy for Rheumatoid Arthritis gets Approval to Start Clinical Trials

06:16 EST 17 Feb 2017 | Labiotech.eu

Arthrogen will start a Phase Ib trial for a gene therapy aiming to treat rheumatoid arthritis with a single injection and reduce costs for patients. Arthrogen, based in Amsterdam, is developing local gene therapies for inflammatory diseases. The biotech company has ...

This awesome article Gene Therapy for Rheumatoid Arthritis gets Approval to Start Clinical Trials appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Gene Therapy for Rheumatoid Arthritis gets Approval to Start Clinical Trials

NEXT ARTICLE

More From BioPortfolio on "Gene Therapy for Rheumatoid Arthritis gets Approval to Start Clinical Trials"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...